RAFAEL HOLDINGS, INC. Property, Plant and Equipment, Gross
RAFAEL HOLDINGS, INC. (RFL) had Property, Plant and Equipment, Gross of $2.59 million as of 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-06-11
- 2026-04-30: Property, Plant and Equipment, Gross $2.59M.
- 2026-01-31: Property, Plant and Equipment, Gross $2.59M.
- 2025-10-31: Property, Plant and Equipment, Gross $2.59M.
- 2025-07-31: Property, Plant and Equipment, Gross $2.61M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2026-04-30 | $2.59M 10-Q · filed 2026-06-11 |
| 2026-01-31 | $2.59M 10-Q · filed 2026-03-16 |
| 2025-10-31 | $2.59M 10-Q · filed 2025-12-12 |
| 2025-07-31 | $2.61M 10-Q · filed 2026-06-11 |
| 2025-04-30 | $2.61M 10-Q · filed 2025-06-11 |
| 2025-01-31 | $3.03M 10-Q · filed 2025-03-14 |
| 2024-10-31 | $3.14M 10-Q · filed 2024-12-11 |
| 2024-07-31 | $3.14M 10-K · filed 2025-10-29 |
| 2024-04-30 | $3.13M 10-Q · filed 2024-06-14 |
| 2024-01-31 | $2.98M 10-Q · filed 2024-03-14 |
| 2023-07-31 | $2.57M 10-K/A · filed 2024-12-20 |
| 2022-07-31 | $57.20M 10-Q · filed 2023-06-13 |
| 2021-07-31 | $57.10M 10-K · filed 2022-10-31 |
| 2020-04-30 | $66.54M 10-Q · filed 2020-06-09 |
| 2020-01-31 | $66.51M 10-Q · filed 2020-03-05 |
| 2019-10-31 | $66.37M 10-Q · filed 2019-12-09 |
| 2019-07-31 | $66.05M 10-Q · filed 2020-06-09 |
| 2018-07-31 | $65.65M 10-K · filed 2019-10-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |